U.S. Bankruptcy Judge Christopher Lopez heard opening statements on Tuesday in a two-week trial over the fate of Johnson & Johnson's third talcum powder bankruptcy.
After its potential kidney disease drug went down in flames late last year, Novo Nordisk is pinning the blame on alleged fraudulent claims by the drug’s original maker. | After its potential kidney ...
Johnson & Johnson begins a two-week trial on Feb. 18 over its plan to end tens of thousands of lawsuits filed by women or ...
So we're three and a half years in here at Burke,” Brian Epley said. “We haven't really programmatically started or done a lot.” ...
Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.
The recent settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...
Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...
It’s a conversation that has taken on added urgency as some $50 billion in opioid lawsuit settlement money pours into communities across the country — money that drug makers, including Purdue Pharma, ...
Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results